Immune Cytolytic Activity Correlates with Tumor Microenvironmental Aberrations in Colorectal Cancer

Understanding Immune Heterogeneity in Colorectal Cancer: Towards Precision Immunotherapy

The efficacy of immunotherapy in colorectal cancer (CRC) is heavily dictated by the complex interplay between the tumor’s genomic landscape and its immune microenvironment. Recent immunogenomic analyses reveal that patient stratification based on cytolytic activity and immune competency is essential for optimizing clinical outcomes.

The Impact of Cytolytic Activity (CYT) on Treatment Response

Not all CRC tumors respond to immune checkpoint inhibitors (ICIs) equally. The distinction between CYT-high and CYT-low subgroups provides a critical framework for predicting therapeutic success:

• CYT-high & Immune-Competent Tumors: These emerge as the strongest candidates for immunotherapy due to higher levels of T-cell infiltration and sustained cytotoxic activity
• MSS and CYT-low Tumors: These “immunologically cold” tumors present significant challenges, characterized by immune exclusion, intrinsic resistance, and a highly suppressive tumor microenvironment (TME)

Decoding the Tumor Microenvironment (TME) and Chemokine Gradients

Effective antitumor immunity requires more than the presence of immune cells; it necessitates efficient infiltration and functional activation.
The study highlight specific molecular drivers of this process:

• T-cell Recruitment: Expression of CXCR3 and CXCL13 is associated with increased immune infiltration, B-cell recruitment, and the formation of tertiary lymphoid structures, which enhance local antitumor control
• Immune Suppression: Conversely, the expression of complement proteins such as C1QA, C1QB, and C1QC correlates with macrophage infiltration and polarization, contributing to an immunosuppressive environment

To overcome resistance in MSS CRC, future strategies may need to combine ICIs with therapies that reprogram these suppressive components and boost T-cell effector functions

The Link Between Chromothripsis and Immune Profiling

Beyond soluble factors, large-scale genomic alterations play a pivotal role in immune shaping. Chromothripsis—the catastrophic shattering and disorganized reassembly of one or more chromosomes—has been identified as a key factor in CRC heterogeneity.
Analysis across different cytolytic subgroups shows that chromothriptic events vary significantly:

• High-confidence chromothripsis events are frequently observed, often affecting single chromosomes
• These genomic instabilities, alongside pathogenic indels and structural variations (SVs), contribute to the overall immunophenotype of the tumor, particularly within specific immune-deficient (ID) subgroups.

Conclusion: The Future of Precision Immuno-Oncology

The integration of CYT scores, chemokine profiles, and genomic features like chromothripsis allows for a more granular stratification of CRC patients. By moving beyond binary classifications, we can develop biomarker-driven combination therapies tailored to the specific immunogenomic profile of each patient